Erytech Pharma reports Q3 results
…
0,422€
-2,09%
Echtzeit-Aktienkurs ERYTECH PHARMA SA EO-,10
Bid:
Ask:
Nachrichten zur ERYTECH PHARMA SA EO-,10 Aktie
THE MARKET BACKS AKKADIAN PARTNERS AND CONDEMNS THE MERGER BETWEEN ERYTECH AND PHERECYDES
Full and original release on www.actusnews.com.
Subscribe to this companys information....…
Form 6-K Erytech Pharma S.A. For: Jun 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics...…
Form 6-K Erytech Pharma S.A. For: Jun 20
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit...…
Form 6-K Erytech Pharma S.A. For: Jun 14
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AKKADIAN PARTNERS REJECTS THE LIQUIDATION OF ERYTECH IN THE EVENT THAT THE MERGER WITH PHERECYDES FAILS
Full and original release on www.actusnews.com.
Subscribe to this companys information....…
Form 6-K Erytech Pharma S.A. For: Jun 12
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akkadian Partners SA: Akkadian Suggests to Erytech an Alternative Strategy to its Merger with Pherecydes
Review of the true value of Erytechs assetsProposed strategy for ErytechAudit report requested by Akkadian stating the undervaluation of Erytechand…
AKKADIAN PARTNERS : Akkadian suggests to Erytech an alternative strategy to its merger with Pherecydes
Full and original release on www.actusnews.com.
Subscribe to this companys information....…
Form 6-K Erytech Pharma S.A. For: Jun 05
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes...…
Form 6-K Erytech Pharma S.A. For: May 24
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023...…
Form 6-K Erytech Pharma S.A. For: May 15
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akkadian Partners SA: Akkadian Partners Fund has Acquired Over a 5% Shareholding and Voting Rights in Erytech and Intends to Vote Against the Merger between Erytech and Pherecydes
PARIS, FRANCE/ ACCESSWIRE / May 16, 2023 / Akkadian Partners SA ("Akkadian") has announced that Akkadian Partners Fund, a Luxemburg…
ERYTECH Provides Update on the Announced Combination with PHERECYDES
ERYTECH Provides Update on the Announced Combination with PHERECYDES ...…
AKKADIAN PARTNERS : Akkadian Partners Fund has acquired over a 5% shareholding and voting rights in Erytech and intends to vote against the merger between Erytech and Pherecydes
Full and original release on www.actusnews.com.
Subscribe to this companys information....…
AKKADIAN PARTNERS : Akkadian Partners Fund has acquired over a 5% shareholding and voting rights in Erytech
Full and original release on www.actusnews.com.
Subscribe to this companys information....…
Erytech Pharma reports Q1 results
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K Erytech Pharma S.A. For: Apr 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
ERYTECH receives approval to transfer its listing to Nasdaq Capital Market
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market...…
Form 6-K Erytech Pharma S.A. For: Mar 22
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Erytech Pharma reports FY results
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022 ...…
Form 6-K Erytech Pharma S.A. For: Feb 16
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…